Guggenheim Capital LLC Viatris Inc Transaction History
Guggenheim Capital LLC
- $12 Billion
- Q4 2024
A detailed history of Guggenheim Capital LLC transactions in Viatris Inc stock. As of the latest transaction made, Guggenheim Capital LLC holds 898,800 shares of VTRS stock, worth $8.3 Million. This represents 0.09% of its overall portfolio holdings.
Number of Shares
898,800
Previous 959,605
6.34%
Holding current value
$8.3 Million
Previous $11.1 Million
0.44%
% of portfolio
0.09%
Previous 0.08%
Shares
17 transactions
Others Institutions Holding VTRS
# of Institutions
1,140Shares Held
988MCall Options Held
2.34MPut Options Held
2.21M-
Vanguard Group Inc Valley Forge, PA142MShares$1.31 Billion0.03% of portfolio
-
Black Rock Inc. New York, NY92.7MShares$855 Million0.02% of portfolio
-
State Street Corp Boston, MA63.7MShares$588 Million0.03% of portfolio
-
Chris Davis Davis Selected Advisers | Tucson, Az62.6MShares$578 Million4.62% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD58.7MShares$542 Million0.08% of portfolio
About Viatris Inc
- Ticker VTRS
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 1,212,669,952
- Market Cap $11.2B
- Description
- Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...